FDA
Medroxyprogesterone Acetate
The FDA lists this product in 20 strengths and forms.
Composition
- Active ingredients
- MEDROXYPROGESTERONE ACETATE 150MG/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- MEDROXYPROGESTERONE ACETATE 5MG · TabletANDA040311-002 · Discontinued
- MEDROXYPROGESTERONE ACETATE 10MG · TabletANDA040311-003 · Discontinued
- MEDROXYPROGESTERONE ACETATE 2.5MG · TabletANDA040311-001 · Discontinued
- MEDROXYPROGESTERONE ACETATE 150MG/ML · InjectableANDA076552-001 · Discontinued
- MEDROXYPROGESTERONE ACETATE 150MG/ML · InjectableANDA215397-001 · Prescription
- MEDROXYPROGESTERONE ACETATE 150MG/ML · InjectableANDA077235-001 · Prescription
- MEDROXYPROGESTERONE ACETATE 150MG/ML · InjectableANDA077334-001 · Prescription
- MEDROXYPROGESTERONE ACETATE 10MG · TabletANDA088484-001 · Discontinued
- MEDROXYPROGESTERONE ACETATE 150MG/ML · InjectableANDA214309-001 · Discontinued
- MEDROXYPROGESTERONE ACETATE 150MG/ML · InjectableANDA076553-001 · Prescription
At a glance
- Brand name
- Medroxyprogesterone Acetate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Cipla
- Status
- Discontinued
- FDA approval
- 25 Jan 2019
- Application
- ANDA210335-001